2020
DOI: 10.1093/mutage/geaa011
|View full text |Cite
|
Sign up to set email alerts
|

Potassium bromate as positive assay control for the Fpg-modified comet assay

Abstract: The comet assay is a popular assay in biomonitoring studies. DNA strand breaks (or unspecific DNA lesions) are measured using the standard comet assay. Oxidative stress-generated DNA lesions can be measured by employing DNA repair enzymes to recognise oxidatively damaged DNA. Unfortunately, there has been a tendency to fail to report results from assay controls (or maybe even not to employ assay controls). We believe this might have been due to uncertainty as to what really constitutes a positive control. It s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

4
3

Authors

Journals

citations
Cited by 33 publications
(23 citation statements)
references
References 28 publications
1
15
0
Order By: Relevance
“…hOGG1-modified comet assay has been widely used in human biomonitoring studies to detect oxidative DNA damage (Azqueta et al 2020). As it was previously described (Møller et al 2018), KBrO 3 causes oxidative damage to bases but do not generate DNA strand breaks, demonstrating that it is a suitable positive control for the enzyme-modified comet assay (Møller et al 2020b). Besides, KBrO 3 is known to induce hOGG1sensitive sites (Smith et al 2006;Pfuhler et al 2017).…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…hOGG1-modified comet assay has been widely used in human biomonitoring studies to detect oxidative DNA damage (Azqueta et al 2020). As it was previously described (Møller et al 2018), KBrO 3 causes oxidative damage to bases but do not generate DNA strand breaks, demonstrating that it is a suitable positive control for the enzyme-modified comet assay (Møller et al 2020b). Besides, KBrO 3 is known to induce hOGG1sensitive sites (Smith et al 2006;Pfuhler et al 2017).…”
Section: Discussionmentioning
confidence: 95%
“…Fresh and frozen saliva leucocytes and frozen PBL were exposed to four well-known DNA damaging agents: MMS, Act-D, ultraviolet (UV) radiation, and KBrO 3 . The doses used, as well as the treatment times, were selected on the basis of previous studies (Collins et al 1997;Sánchez-Flores et al 2015;Laffon et al 2017;Møller et al 2020b).…”
Section: Treatmentsmentioning
confidence: 99%
“…ECVAG was superseded by the comet assay in human biomonitoring (hCOMET) project that has disseminated recommendations on technical procedures, , molecular epidemiological studies, and reporting of results . The hCOMET project also included a ring trial on the Fpg-modified comet assay, aiming at testing KBrO 3 as positive assay control …”
Section: Validity Of Methods For Detection Of Oxidatively Damaged Dnamentioning
confidence: 99%
“…Overall, the ESCODD ring trials show that interlaboratory variation (i.e., ratios between the highest and lowest values in background levels of 8-oxodG) increases as the sample becomes more complex, that is, 5.1-fold (8-oxodG standard in solution), 7.8-fold (calf thymus DNA), 10–100-fold (HeLa cells), 35-fold (PBMCs), and 100-fold (pig liver). , In comparison, the variation in Fpg-sensitive sites is <10-fold in cells that have been distributed from a central laboratory to partner laboratories. The hCOMET trial assessed the variation in Fpg-sensitive sites in both reference samples (Ro19-8022 treated cells) and cells that were exposed to KBrO 3 in each of the participating laboratories and analyzed by a semistandardized comet assay procedure. The results showed a relatively high variation in the level of Fpg-sensitive sites in cells after KBrO 3 exposure (58-, 91-, 46-, and 13-fold between lowest and highest values after exposure to 0, 0.5, 1.5, and 4.5 mM, respectively) . However, all laboratories obtained a concentration–response relationship and found that the Ro19-8022 reference sample had levels of Fpg-sensitive sites that were within the range of the DNA damage of the KBrO 3 samples.…”
Section: Validity Of Methods For Detection Of Oxidatively Damaged Dnamentioning
confidence: 99%
“…The photosensitizer Ro19-8022, which was used by the ESCODD and ECVAG ring trials, is not widely commercially available, and can be relatively difficult to find. Work performed after the ECVAG studies has identified potassium bromate as a good positive assay control for the hOGG1-and Fpg-modified comet assay [ 298 ]. The stability of potassium bromate-induced DNA damage in cryopreserved samples is currently being investigated, which would be a crucial aspect of any human biomonitoring or clinical study [ 298 ].…”
Section: The Futurementioning
confidence: 99%